PAX5 and precursor B-cell acute lymphoblastic leukemia: To ascertain whether the timing of infection exposure is relevant for B-ALL development in Pax5+/− mice, heterozygous mutant and control littermate WT mice were exposed to the same infectious conditions since pregnancy and birth, and then during the rest of their lifespan (we named this the “early exposure group”) (Fig. 2a).